Big Hong Kong IPOs like CATL help squeeze price gaps of China’s dual-listed companies
A 17 per cent surge since its listing last month has propelled CATL’s Hong Kong-traded shares (H shares) to an 11 per cent premium over their mainland-listed counterparts (A shares), a rarity among the 155 dual-listed companies. And the Hong Kong-listed shares of Hengrui, China’s biggest drug maker by market value, are now nearly on…
